(reported by the Company)
No items found
Carina Biotech: Advanced cellular immunotherapies
We are an Australian biotech company researching and developing broad-spectrum chimeric antigen receptor T cell (CAR-T) technologies to treat solid cancers including pediatric and rare cancers.
We are working toâ€¦
1. Expand the clinical indications for T cell therapies
2. Improve the commercial viability of T cell therapies by developing supporting technologies that make T cell therapies more effective or economically viable
Headquartered in Adelaide, South Australia, Carina has strong T cell R&D capability across a network of research providers and collaborators including leading scientists at the UniSA, the Women's & Children's Hospital in Adelaide, the University of Adelaide, the Royal Prince Alfred Hospital in NSW and the Seattle Children's Hospital in the United States.
|Category:||Health & biotech|
|ASX Listing Code (if applicable):|
|Year of Commencement:||2016|
Level 5, Catherine Helen Spence Building, UniSA City West Campus, Adelaide , South Australia 5000, AU